Wells Fargo & Company Has Lowered Expectations for Healthpeak Properties (NYSE:DOC) Stock Price

Key Points

• Wells Fargo lowered Healthpeak Properties’ price target from $22 to $19 while maintaining an “equal weight” rating, implying approximately 2.79% upside from the stock’s reported $18.48 price.
• Analyst sentiment remains cautious: four analysts rate the stock a Buy and 14 rate it Hold, resulting in a consensus “Hold” rating and an average target price of $21.60.
• Healthpeak reported quarterly earnings of $0.08 per share, exceeding estimates of $0.03, while revenue rose 11.1% year over year to $771.58 million. Institutional investors own 93.57% of the company.

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price objective reduced by equities research analysts at Wells Fargo & Company from $22.00 to $19.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has an "equal weight" rating on the real estate investment trust's stock. Wells Fargo & Company's target price indicates a potential upside of 2.79% from the stock's current price.

Several other equities analysts have also recently issued reports on the stock. UBS Group decreased their price target on shares of Healthpeak Properties from $21.50 to $20.00 and set a "neutral" rating for the company in a research report on Tuesday, October 13th. Mizuho boosted their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, July 6th. Royal Bank Of Canada raised their price objective on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, August 10th. Robert W. Baird increased their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the stock an "outperform" rating in a research note on Thursday, August 13th. Finally, Citigroup raised their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $21.60.

Healthpeak Properties Price Performance

NYSE DOC traded down $0.49 during trading on Monday, hitting $18.48. 1,948,815 shares of the company's stock were exchanged, compared to its average volume of 7,735,198. The company has a market cap of $12.75 billion, a PE ratio of 52.82, a P/E/G ratio of 2.35 and a beta of 1.01. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. The stock's 50 day moving average price is $20.26 and its two-hundred day moving average price is $19.89. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95.

Healthpeak Properties (NYSE:DOC - Get Free Report) last issued its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same quarter last year, the business posted $0.46 earnings per share. The company's quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts expect that Healthpeak Properties will post 1.77 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. SteelPeak Wealth LLC increased its stake in Healthpeak Properties by 62.1% in the 3rd quarter. SteelPeak Wealth LLC now owns 91,979 shares of the real estate investment trust's stock worth $1,837,000 after purchasing an additional 35,251 shares during the period. IFP Advisors Inc increased its position in shares of Healthpeak Properties by 359.4% in the third quarter. IFP Advisors Inc now owns 34,326 shares of the real estate investment trust's stock valued at $685,000 after acquiring an additional 26,854 shares during the period. Robertson Stephens Wealth Management LLC raised its stake in shares of Healthpeak Properties by 55.5% during the third quarter. Robertson Stephens Wealth Management LLC now owns 32,873 shares of the real estate investment trust's stock valued at $656,000 after acquiring an additional 11,733 shares during the last quarter. AlphaStar Capital Management LLC lifted its holdings in Healthpeak Properties by 53.2% in the 3rd quarter. AlphaStar Capital Management LLC now owns 20,147 shares of the real estate investment trust's stock worth $402,000 after buying an additional 6,994 shares during the period. Finally, 1834 Investment Advisors Co. boosted its stake in shares of Healthpeak Properties by 3.4% during the 3rd quarter. 1834 Investment Advisors Co. now owns 206,239 shares of the real estate investment trust's stock valued at $4,119,000 after purchasing an additional 6,719 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc NYSE: DOC is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.